drugset / Trial / NCT03606018
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects
RandomizedCrossoverSingle-blindBasic science
Summary
Pharmacokinetics and pharmacodynamics study Study of 2 formulation of insulin lispro mix 25 (Insulin Lispro Mix 25 GEROPHARM vers. Humalog® Mix 25 Eli Lilly)
Timeline
- Start
- 2017-04-12
- Primary completion
- 2017-07-13
- Completion
- 2017-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Humalog® Mix25 | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |
| Subject | Insulin Lispro Mix25 | Unknown | 0.4 iu/kg | Subcutaneous |
Indications
No indication recorded.